Clinical Trials Browser

Interventional × Carcinoma, Neuroendocrine × iadademstat × Clear all

NCT05420636 2025-07-30

Iadademstat in Combination With Paclitaxel in Relapsed/Refractory SCLC and Extrapulmonary High Grade NET

Phase 2 Terminated

EndocrineThoracic

Carcinoma, Neuroendocrine, Small Cell Lung Carcinoma